Juniper Advisory Promotes Casey Webb to Managing Director
CHICAGO, IL / ACCESSWIRE / September 13, 2023 / Juniper Advisory is pleased to announce the promotion of Casey Webb...
CHICAGO, IL / ACCESSWIRE / September 13, 2023 / Juniper Advisory is pleased to announce the promotion of Casey Webb...
Hospital transitions to AUC-based dosing to achieve a comprehensive view of patient course of therapy, renal function, and overall population...
One Year Since Founder to CEO Transition, Oxeon Welcomes Duncan Reece as President and Opens Nashville OfficeNASHVILLE, Tenn.--(BUSINESS WIRE)--Oxeon, an...
CognICA Chosen as Winner of Best AI Product in Healthcare Award at CogX FestivalVancouver, British Columbia--(Newsfile Corp. - September 13,...
Pharmacy benefit manager's new brand pillars leverage strengths to better serve their partners and clients.MILWAUKEE, WI / ACCESSWIRE / September...
The acquisition enhances patient care and extends CLS Health's geographical reach in the Houston area.HOUSTON, TX / ACCESSWIRE / September...
New patent issued to Napo Pharmaceuticals, a Jaguar Health family company, for core rare disease target indication for crofelemerJaguar is...
CHICAGO, IL / ACCESSWIRE / September 13, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
LIEGE, BELGIUM / ACCESSWIRE / September 13, 2023 / Imcyse, a clinical-stage biopharmaceutical company pioneering the development of a new...
Mark H. Stouffer, MD and team from Zion Surgery Center successfully perform multiple Catamaran cases with JIB Instrument Kit in...
ENGLEWOOD, CO / ACCESSWIRE / September 13, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (Nasdaq:AYTU), a pharmaceutical company...
Biotricitys New Digital Presence Reflects Commitment to Innovation in the Healthcare Space.REDWOOD CITY, CA / ACCESSWIRE / September 13, 2023...
Company's flu vaccine, mRNA-1010, met its primary endpoint in Phase 3 trial; separate Phase 1/2 data demonstrated higher HAI titers...
PALO ALTO, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), a majority-owned subsidiary...
Supply of drug substance manufactured under cGMP supports first-in-human clinical study for RBI-4000 novel self-replicating RNA (srRNA)ALBANY, N.Y., Sept. 13,...
CARMEL, Ind., Sept. 13, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NYSE American: NRXS), (“NeurAxis,” or the “Company”), a medical technology...
NEW YORK and VIENNA, Sept. 13, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a...
AHCC Impact on HPV Two studies published in the Frontiers in Oncology journal have showcased the potential of AHCC supplementation...
Program will feature executive management plus key opinion leaders in immuno-oncology and vaccine development LAWRENCEVILLE, N.J., Sept. 13, 2023 (GLOBE...
The FDA’s response indicated that the planned toxicity study strategy is acceptable under FDA guidelines and large-scale animal studies will...